<DOC>
	<DOCNO>NCT00053716</DOCNO>
	<brief_summary>This first clinical research trial intravenous Prostaglandin E1 ( PGE1 vasoactive hormone ) use supportive treatment along angioplasty procedure treat open block artery within one low limb affect two limbs subject Peripheral Arterial Occlusive Disease .</brief_summary>
	<brief_title>Prostaglandin E1 ( Liprostin ) Treatment With Lower Limb Angioplasty Peripheral Arterial Occlusive Disease</brief_title>
	<detailed_description>PAOD result decrease arterial blood flow lower limb foot symptom include , pain rest , numb sensation limb foot , limited ability walk pain occur . PAOD occur along diabetic ulcer . Proposed treatment give medical center overnight hospital stay . Treatment include angioplasty open one two occluded artery low limb plus drug ( Liprostin ) special formulation liposomal Prostaglandin E1 , PGE1 , natural occur vasoactive hormone ) . Drug treatment give twice artery treat , angioplasty . When angioplasty procedure complete , 12 hour intravenous infusion Liprostin give complete treatment procedure . A total 12 PAOD subject enrol single center : Memorial Hermann Hospital , Houston , TX . Study begin February , 2003 last ( 12th ) subject enrol , likely August , 20</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Alprostadil</mesh_term>
	<criteria>Male female subject , 18 year old Diagnosis Peripheral Arterial Occlusive Disease [ PAOD ] Subject candidate immediate angioplasty low limb Subject must complete 2 treadmill test Screen walk distance limit PAOD due angina fatigue Lower limb peripheral revascularization procedure past 3 month History myocardial infarction past 6 month Malignant disease , uncontrolled hypertension Class III heart failure Aortic occlusion , thrombose popliteal aneurysm , severe hemorrhagic disorder , long iliac occlusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2004</verification_date>
	<keyword>Angioplasty &amp; PGE1 Treatment Peripheral Vascular Disease</keyword>
</DOC>